Warby Parker (WRBY) Current Deferred Revenue (2020 - 2026)
Warby Parker's (WRBY) quarterly Current Deferred Revenue came in at $20.9 million in Q1 2026, down 7.12% YoY from $22.5 million in Q1 2025, and down 38.27% on a QoQ basis from $33.9 million in Q4 2025.
Warby Parker (WRBY) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Current Deferred Revenue data on file, last reported at $20.9 million in Q1 2026.
- Quarterly Current Deferred Revenue fell 7.12% year-over-year to $20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (down 7.12% YoY) and the FY2025 annual result came in at $33.9 million, up 4.67% from the prior year.
- Current Deferred Revenue declined to $20.9 million in Q1 2026, from $33.9 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $33.9 million in Q4 2025 to a low of $16.3 million in Q3 2022.
- A 5-year average of $22.4 million and a median of $21.1 million in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue increased 23.37% — and 2026, when it dropped 7.12%.
- Tracing WRBY's Current Deferred Revenue over 5 years: stood at $25.6 million in 2022, then rose by 23.37% to $31.6 million in 2023, then rose by 2.34% to $32.4 million in 2024, then climbed by 4.67% to $33.9 million in 2025, then tumbled by 38.27% to $20.9 million in 2026.
- The last three Current Deferred Revenue figures came in at $20.9 million (Q1 2026), $33.9 million (Q4 2025), and $22.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.57 Mn |
| Mar 31, 2026 | 20.91 Mn |
| Dec 31, 2025 | 33.87 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 21.52 Mn |
| Mar 31, 2025 | 22.51 Mn |
| Dec 31, 2024 | 32.36 Mn |
| Sep 30, 2024 | 19.22 Mn |
| Jun 30, 2024 | 21.05 Mn |
| Mar 31, 2024 | 21.24 Mn |
| Dec 31, 2023 | 31.62 Mn |
| Sep 30, 2023 | 17.62 Mn |
| Jun 30, 2023 | 18.95 Mn |
| Mar 31, 2023 | 18.89 Mn |
| Dec 31, 2022 | 25.63 Mn |
| Sep 30, 2022 | 16.26 Mn |
| Jun 30, 2022 | 18.31 Mn |
| Mar 31, 2022 | 19.42 Mn |
| Dec 31, 2021 | 22.07 Mn |
| Sep 30, 2021 | 16.78 Mn |